Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454921 · ClinicalTrials.gov registry record · Phase 2
Development of an Empowerment Intervention for Young Women Living With HIV
A Phase 2 study of HIV, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
- 3
- Study locations
NCT01454921 is a Phase 2 study of HIV that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 43 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01454921, a Phase 2 study of HIV, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will develop/adapt a culturally appropriate secondary prevention intervention for young, Human Immunodeficiency Virus (HIV)-positive women through intervention groups, evaluate its acceptability and feasibility, make appropriate modifications, and manualize the intervention in preparation for a full-scale randomized trial. Once the intervention is developed/adapted, the sites will pilot the interventions twice to enable modifications. The intervention aims to address the following concerns: 1) reducing the risk of young women infected with HIV transmitting the virus to their sexual partners, and 2) preventing young women infected with HIV from re-infection with a new viral strain or co-infection with another sexually transmitted disease (STD). Data will be collected to assess the feasibility and acceptability of the newly developed intervention using both quantitative and qualitative methods at each iteration.
Conditions Studied
Interventions
- BEHAVIORAL Evolution: Young Women Taking Charge and Growing Stronger
Study Locations (3)
Florida
- USF College of Medicine - Tampa
Illinois
- Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital - Chicago
Maryland
- University of Maryland Medical School - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01454921
The ClinicalTrials.gov registry entry for NCT01454921 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (90% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Evolution: Young Women Taking Charge and Growing Stronger is the first listed.
NCT01454921 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT01454921 about?
NCT01454921 is a clinical study titled "Development of an Empowerment Intervention for Young Women Living With HIV". This study will develop/adapt a culturally appropriate secondary prevention intervention for young, Human Immunodeficiency Virus (HIV)-positive women through intervention groups, evaluate its acceptability and feasibility, make appropriate modifications, and manualize the intervention in preparation...
What is the current status of trial NCT01454921?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2010-02. Estimated completion is 2011-10.
What conditions does trial NCT01454921 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT01454921?
The interventions under investigation include: Evolution: Young Women Taking Charge and Growing Stronger (BEHAVIORAL).
Who is sponsoring clinical trial NCT01454921?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01454921 being conducted?
This trial has 3 study locations across Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RECRUITING · Phase 2
-
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.